stoxline Quote Chart Rank Option Currency Glossary
Inspire Medical Systems, Inc. (INSP)
157.95  -0.77 (-0.49%)    05-28 16:00
Open: 159.14
High: 160.69
Volume: 375,025
Pre. Close: 158.72
Low: 155.35
Market Cap: 4,693(M)
Technical analysis
2024-05-28 4:23:22 PM
Short term     
Mid term     
Targets 6-month :  252.89 1-year :  300.64
Resists First :  216.51 Second :  257.39
Pivot price 165.6
Supports First :  150.38 Second :  125.11
MAs MA(5) :  157.07 MA(20) :  186.08
MA(100) :  201.24 MA(250) :  213.56
MACD MACD :  -18 Signal :  -16.4
%K %D K(14,3) :  6.3 D(3) :  6.4
RSI RSI(14): 33.8
52-week High :  330 Low :  123.26
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ INSP ] has closed above bottom band by 41.3%. Bollinger Bands are 71.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 13 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 161.06 - 161.86 161.86 - 162.5
Low: 153.18 - 154.24 154.24 - 155.11
Close: 156.44 - 158.07 158.07 - 159.39
Company Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Headline News

Tue, 28 May 2024
60,187 Shares in Inspire Medical Systems, Inc. (NYSE:INSP) Purchased by Nomura Asset Management Co. Ltd. - MarketBeat

Tue, 28 May 2024
Assetmark Inc. Acquires 494 Shares of Inspire Medical Systems, Inc. (NYSE:INSP) - Defense World

Sun, 26 May 2024
Vanguard Personalized Indexing Management LLC Decreases Holdings in Inspire Medical Systems, Inc. (NYSE:INSP) - Defense World

Sun, 26 May 2024
Westfield Capital Management Co. LP Sells 186,781 Shares of Inspire Medical Systems, Inc. (NYSE:INSP) - MarketBeat

Fri, 24 May 2024
Those who invested in Inspire Medical Systems (NYSE:INSP) three years ago are up 292% - Yahoo New Zealand News

Fri, 24 May 2024
Great Lakes Advisors LLC Acquires Shares of 986 Inspire Medical Systems, Inc. (NYSE:INSP) - Defense World

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Devices
Shares Out 30 (M)
Shares Float 29 (M)
Held by Insiders 1.9 (%)
Held by Institutions 107.4 (%)
Shares Short 2,300 (K)
Shares Short P.Month 2,080 (K)
Stock Financials
EPS -0.55
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 19.85
Profit Margin -2.4 %
Operating Margin -9.3 %
Return on Assets (ttm) -3.6 %
Return on Equity (ttm) -2.9 %
Qtrly Rev. Growth 28.2 %
Gross Profit (p.s.) 0
Sales Per Share 22.24
EBITDA (p.s.) -1.11
Qtrly Earnings Growth 0 %
Operating Cash Flow 35 (M)
Levered Free Cash Flow 4 (M)
Stock Valuations
PE Ratio -292.5
PEG Ratio 46
Price to Book value 7.95
Price to Sales 7.1
Price to Cash Flow 134.61
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android